Secondary |
Product Used For Unknown Indication |
64.1% |
Drug Use For Unknown Indication |
15.4% |
Atrial Fibrillation |
5.1% |
Cerebrovascular Accident Prophylaxis |
5.1% |
Ill-defined Disorder |
5.1% |
Pain |
5.1% |
|
Loss Of Consciousness |
16.7% |
Dyslalia |
8.3% |
Long Qt Syndrome |
8.3% |
Multiple Drug Overdose |
8.3% |
Neutrophil Pelger-huet Anomaly Present |
8.3% |
Oedema Due To Cardiac Disease |
8.3% |
Product Quality Issue |
8.3% |
Serotonin Syndrome |
8.3% |
Suicide Attempt |
8.3% |
Tardive Dyskinesia |
8.3% |
Toxicity To Various Agents |
8.3% |
|
Concomitant |
Product Used For Unknown Indication |
19.5% |
Back Pain |
19.2% |
Pain |
16.7% |
Drug Use For Unknown Indication |
7.3% |
Arthritis |
7.0% |
Arthralgia |
5.2% |
Pain In Extremity |
3.8% |
Hypertension |
3.1% |
Neuralgia |
2.4% |
Behcet's Syndrome |
2.1% |
Osteoarthritis |
2.1% |
Depression |
1.7% |
Breakthrough Pain |
1.4% |
Cardiac Failure Congestive |
1.4% |
Chronic Obstructive Pulmonary Disease |
1.4% |
Fibromyalgia |
1.4% |
Asthma |
1.0% |
Bone Pain |
1.0% |
Cancer Pain |
1.0% |
Dyspepsia |
1.0% |
|
Wrong Technique In Drug Usage Process |
51.6% |
Product Quality Issue |
5.6% |
Drug Administered At Inappropriate Site |
4.8% |
Product Adhesion Issue |
4.0% |
Gait Disturbance |
3.2% |
Inappropriate Schedule Of Drug Administration |
3.2% |
Completed Suicide |
2.4% |
Drug Ineffective |
2.4% |
Incorrect Dose Administered |
2.4% |
Pain |
2.4% |
Suicide Attempt |
2.4% |
Vision Blurred |
2.4% |
Weight Decreased |
2.4% |
Back Injury |
1.6% |
Dementia |
1.6% |
Neoplasm Skin |
1.6% |
Rash |
1.6% |
Respiratory Disorder |
1.6% |
Treatment Noncompliance |
1.6% |
Vomiting |
1.6% |
|
Interacting |
Product Used For Unknown Indication |
100.0% |
|
|